Faculty

Faculty

Wu, Chun-Ying / 吳俊穎

Institute of Biomedical Informatics

 02-2826-7000#67155
 02-2820-2508
 cywu4@nycu.edu.tw


Current Position

Associate Dean and Chair Professor, College of Medicine, National Yang Ming Chiao Tung University

Director, Professor, Institute of Biomedical Informatics, National Yang Ming Chiao Tung University

Chief, Division of Translational Research, Taipei Veterans General Hospital

Professor, Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital

 

Office

R327-1, 3F, Shou-Ren Building


Academic Degrees

M.D., Ph.D., National Taiwan University, Taiwan

M.P.H., Quantitative Method, and LL.M., Health Law, Harvard University

 

Representative honors

NSTC, Outstanding Research Awards, 2015 and 2021

The Best 9 Article of NYMU, 2020 

Medical Model Award, 2018

National Innovation Award, 2016

Outstanding Research Award, 2015

Asia Pacific Emerging Leadership Lecturer, 2015

Best Teaching Lectureship Glass Award, NYMU, 2013

Advances in Digestive Medicine (Editor-in-Chief)

Journal of Gastroenterology & Hepatology (Associate Editor)

Gut (Editor)

 
Research Interests

Health Big Data Research and meta-analysis

Digestive Cancer Translational Research

Gut Microbiota Research

Empirical Legal Research and biotechnology regulation

 

Selected Publications


  • Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY*. Association of daily aspirin therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B.
    JAMA Intern Med 2019 May 1; 179(5): 633-40 (SCI, IF 44.409, 7/172)
  • Yeo YH, Ho HJ, Yang HI…, Wu CY*, Nguyen MH. The HBsAg seroclearance rate and predictors in adults with chronic hepatitis B: a systematic review and meta-analysis. 
    Gastroenterology 2019 Feb; 156(3): 635-46 (SCI, IF 33.883, 3/93) 
  • Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, Wu CY*. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.
    Gut 2018 Jan; 67(1): 20-7 (SCI, IF 31.793, 4/93)
  • Wu CY*, Ho HJ, Wu CY, Chen YJ, Lee TY, Hsu YC, Lin JT. Association between proton pump inhibitor use and mortality in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor. Gut 2021 Sep 9; gutjnl-2020-321932 (online ahead of print) (SCI, IF 31.793, 4/93)
  • Hsu YC, Yip TCF, Ho HJ, Wong VWS, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GLH, Wu CY*. Predicting hepatocellular carcinoma with population-wide data in previously untreated Asians on antivirals for chronic hepatitis B.
    J Hepatol 2018 Aug; 69(2): 278-85 (SCI, IF 30.083, 5/93)